[1] |
Chen Shuai, Yang Changqing..
Pathogenesis and risk factors of portal vein thrombosis
[J]. Journal of Practical Hepatology, 2019, 22(6): 761-764.
|
[2] |
National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association.
Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association
[J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
|
[3] |
chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al..
Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with
[J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
|
[4] |
patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al..
Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in
[J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
|
[5] |
Gao Wei, Hou Yong.
Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
|
[6] |
Xu Qilin, Hao Shaohuan, Ran Bo.
Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis and portal hypertension
[J]. Journal of Practical Hepatology, 2019, 22(5): 708-711.
|
[7] |
Qiu Jun, Wang Xueqing, Zhang Bo, et al.
Percutaneous choledocholithotomy for the treatment of patients with intrahepatic bile duct stones
[J]. Journal of Practical Hepatology, 2019, 22(5): 744-747.
|
[8] |
Bai Yichun, Deng Jihong, Mei Xiaoping.
Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
|
[9] |
Zhang Yafei, Ye Jun, Xie Qinxiu, et al.
Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
|
[10] |
Zhang Wei, Shi Junmei, Wang Qian.
Fisk factors for occurrence of hyperbilirubinemia in neonates
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 534-536.
|
[11] |
Li Fang, Zou Guizhou, Ye Jun, et al.
Clinical features and risk factors of patients with decompensated cirrhosis and sepsis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 557-560.
|
[12] |
Wang Baodan, Li Meng, Gao Yu.
Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
|
[13] |
Du Min, Zhou Min, Ji Zongshu.
Clinical features and risk factors of liver injuries in patients with sepsis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 369-372.
|
[14] |
Liu Wenbo, Zhang Jianye, Bao Jiwu.
Analysis of risk factors for stone recurrence in patients with common bile duct stones after ERCP and EST therapy
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 437-440.
|
[15] |
Jiang Yi, Liu Bing.
Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
|